Michelle Gilmor

893 total citations
19 papers, 702 citations indexed

About

Michelle Gilmor is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Michelle Gilmor has authored 19 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Michelle Gilmor's work include Neuroscience and Neuropharmacology Research (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Lysosomal Storage Disorders Research (4 papers). Michelle Gilmor is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Lysosomal Storage Disorders Research (4 papers). Michelle Gilmor collaborates with scholars based in United States, Brazil and France. Michelle Gilmor's co-authors include Allan I. Levey, Elliott J. Mufson, David A. Bennett, Charles B. Nemeroff, Michael J. Owens, Louis B. Hersh, Susan T. Rouse, Jeffrey D. Erickson, Elizabeth J. Cochran and Elizabeth J. Cochran and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Psychiatry and Neurology.

In The Last Decade

Michelle Gilmor

14 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Gilmor United States	9	342	260	234	228	146	19	702
Ivan Goussakov United States	13	658 1.9×	391 1.5×	358 1.5×	164 0.7×	169 1.2×	20	992
Ken Koda Japan	13	246 0.7×	201 0.8×	107 0.5×	135 0.6×	123 0.8×	17	658
Christopher Q. Mountjoy United Kingdom	5	222 0.6×	162 0.6×	247 1.1×	156 0.7×	146 1.0×	8	591
Luis Pennanen Switzerland	8	233 0.7×	247 0.9×	449 1.9×	133 0.6×	120 0.8×	9	709
Vahram Haroutunian United States	7	212 0.6×	292 1.1×	193 0.8×	157 0.7×	115 0.8×	9	691
Jasmin Bartl Germany	16	298 0.9×	225 0.9×	336 1.4×	100 0.4×	80 0.5×	27	776
M.B. Hesselink Netherlands	18	665 1.9×	403 1.6×	135 0.6×	118 0.5×	128 0.9×	30	955
Laura M. Gault United States	16	431 1.3×	349 1.3×	180 0.8×	174 0.8×	124 0.8×	24	1.0k
Iria G. Dopeso‐Reyes Spain	13	338 1.0×	264 1.0×	135 0.6×	222 1.0×	71 0.5×	17	738
Carole Puma Canada	14	398 1.2×	243 0.9×	159 0.7×	112 0.5×	187 1.3×	17	694

Countries citing papers authored by Michelle Gilmor

Since Specialization

Citations

This map shows the geographic impact of Michelle Gilmor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Gilmor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Gilmor more than expected).

Fields of papers citing papers by Michelle Gilmor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Gilmor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Gilmor. The network helps show where Michelle Gilmor may publish in the future.

Co-authorship network of co-authors of Michelle Gilmor

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Gilmor. A scholar is included among the top collaborators of Michelle Gilmor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Gilmor. Michelle Gilmor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Robinson, Donald S., Michelle Gilmor, Albert J. Azzaro, et al.. (2025). Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials. Psychopharmacology Bulletin. 40(3). 15–28.

Bateman-House, Alison, et al.. (2024). Lived Experience of Patients and Caregivers in Rare Genetic Neurological Gene Therapy Clinical Trials in Children. Pediatric Neurology. 163. 46–49.

Veerapandiyan, Aravindhan, Vamshi K. Rao, Carolina Tesi Rocha, et al.. (2024). 407P RGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy: interim clinical data. Neuromuscular Disorders. 43. 104441.278–104441.278.

Harmatz, Paul, Can Fıçıcıoğlu, Roberto Giugliani, et al.. (2024). CAMPSIITE™ phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II). Molecular Genetics and Metabolism. 141(2). 107874–107874. 1 indexed citations

Wang, Raymond, Nina Movsesyan, Shih‐hsin Kan, et al.. (2024). First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up. Molecular Genetics and Metabolism. 141(2). 108070–108070. 1 indexed citations

Veerapandiyan, Aravindhan, Vamshi K. Rao, Jahannaz Dastgir, et al.. (2024). RGX-202, an Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy: Interim Clinical Data (S21.005). Neurology. 102(7_supplement_1). 1 indexed citations

Pisani, Laura, Can Fıçıcıoğlu, Paul Harmatz, et al.. (2024). CAMPSIITE™ Phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II). Molecular Genetics and Metabolism. 141(4). 108245–108245.

Gilmor, Michelle, Raymond Wang, Can Fıçıcıoğlu, et al.. (2023). RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM THE FIRST IN HUMAN STUDY. Molecular Genetics and Metabolism. 138(3). 107416–107416.

Fowler, Joanna S., Jean Logan, Nora D. Volkow, et al.. (2014). Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain. Neuropsychopharmacology. 40(3). 650–657. 55 indexed citations

10.

Gilmor, Michelle, Kelly Skelton, Charles B. Nemeroff, & Michael J. Owens. (2003). The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal Systems. Journal of Pharmacology and Experimental Therapeutics. 305(2). 434–439. 37 indexed citations

11.

Mufson, Elliott J., Shuang Yang, John L. Dills, et al.. (2002). Loss of basal forebrain P75^NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. The Journal of Comparative Neurology. 443(2). 136–153. 172 indexed citations

12.

Gilmor, Michelle, Michael J. Owens, & Charles B. Nemeroff. (2002). Inhibition of Norepinephrine Uptake in Patients With Major Depression Treated With Paroxetine. American Journal of Psychiatry. 159(10). 1702–1710. 64 indexed citations

13.

Cho, Goang‐Won, et al.. (2000). Phosphorylation of the Rat Vesicular Acetylcholine Transporter. Journal of Biological Chemistry. 275(26). 19942–19948. 21 indexed citations

14.

Rouse, Susan T., Sharon M. Edmunds, Hong Yi, Michelle Gilmor, & Allan I. Levey. (2000). Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neuroscience Letters. 284(3). 182–186. 75 indexed citations

15.

Gilmor, Michelle, Jeffrey D. Erickson, Hélène Varoqui, et al.. (1999). Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. The Journal of Comparative Neurology. 411(4). 693–704. 7 indexed citations

16.

Gilmor, Michelle, Jeffrey D. Erickson, Louis B. Hersh, et al.. (1999). Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. The Journal of Comparative Neurology. 411(4). 693–704. 198 indexed citations

17.

Rouse, Susan T., Michelle Gilmor, & Allan I. Levey. (1998). Differential presynaptic and postsynaptic expression of m1–m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse. Neuroscience. 86(1). 221–232. 42 indexed citations

18.

Gilmor, Michelle, Scott Counts, Ronald G. Wiley, & Allan I. Levey. (1998). Coordinate Expression of the Vesicular Acetylcholine Transporter and Choline Acetyltransferase Following Septohippocampal Pathway Lesions. Journal of Neurochemistry. 71(6). 2411–2420. 21 indexed citations

19.

Miller, Gary W., Michelle Gilmor, & Allan I. Levey. (1998). [27] Generation of transporter-specific antibodies. Methods in enzymology on CD-ROM/Methods in enzymology. 296. 407–422. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact